U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
FARLETUZUMAB ECTERIBULIN
USAN   INN  
Official Name English
ERIBULIN/FARLETUZUMAB ANTIBODY DRUG CONJUGATE
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN FOLATE RECEPTOR .ALPHA.) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER, REDUCED, THIOETHER WITH N-(3-(2-(2-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)ETHOXY)E
Common Name English
FARLETUZUMAB ECTERIBULIN [USAN]
Common Name English
MORAB-202
Code English
farletuzumab ecteribulin [INN]
Common Name English
Code System Code Type Description
CAS
2407465-18-1
Created by admin on Sat Dec 16 14:12:17 GMT 2023 , Edited by admin on Sat Dec 16 14:12:17 GMT 2023
PRIMARY
INN
11877
Created by admin on Sat Dec 16 14:12:17 GMT 2023 , Edited by admin on Sat Dec 16 14:12:17 GMT 2023
PRIMARY
USAN
HI-185
Created by admin on Sat Dec 16 14:12:17 GMT 2023 , Edited by admin on Sat Dec 16 14:12:17 GMT 2023
PRIMARY
NCI_THESAURUS
C173946
Created by admin on Sat Dec 16 14:12:17 GMT 2023 , Edited by admin on Sat Dec 16 14:12:17 GMT 2023
PRIMARY
FDA UNII
UVG3B5TZN3
Created by admin on Sat Dec 16 14:12:17 GMT 2023 , Edited by admin on Sat Dec 16 14:12:17 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966